Department of Orthopaedic Surgery, University of Toledo, Toledo, OH 43614, USA.
Mater Sci Eng C Mater Biol Appl. 2013 Oct;33(7):3688-96. doi: 10.1016/j.msec.2013.04.057. Epub 2013 May 4.
The aim of this paper is to develop novel chitosan-zinc oxide nanocomposite films for biomedical applications. The films were fabricated with 1, 5, 10 and 15% w/w of zinc oxide (ZnO) nanoparticles (NPs) incorporated with chitosan (CS) using a simple method. The prepared nanocomposite films were characterized using atomic force microscopy, Raman and X-ray diffraction studies. In addition, nano and micro mechanical properties were measured. It was found that the microhardness, nanohardness and its corresponding elastic modulus increased with the increase of ZnO NP percentage in the CS films. However, the ductility of films decreased as the percentage of ZnO NPs increased. Cell attachment and cytotoxicity of the prepared films at days two and five were evaluated in vitro using osteoblasts (OBs). It was observed that OB viability decreased in films with higher than 5% ZnO NPs. This result suggests that although ZnO NPs can improve the mechanical properties of pure CS films, only a low percentage of ZnO NPs can be applied for biomedical and bioengineering applications because of the cytotoxicity effects of these particles.
本文旨在开发用于生物医学应用的新型壳聚糖-氧化锌纳米复合材料薄膜。通过简单的方法,用 1、5、10 和 15% w/w 的氧化锌 (ZnO) 纳米颗粒 (NPs) 与壳聚糖 (CS) 复合制备纳米复合材料薄膜。使用原子力显微镜、拉曼和 X 射线衍射研究对制备的纳米复合材料进行了表征。此外,还测量了纳米和微观力学性能。结果发现,随着 CS 薄膜中 ZnO NP 百分比的增加,显微硬度、纳米硬度及其相应的弹性模量增加。然而,随着 ZnO NPs 百分比的增加,薄膜的延展性降低。使用成骨细胞 (OBs) 在体外评估了制备的薄膜在第 2 天和第 5 天的细胞附着和细胞毒性。结果发现,含有高于 5% ZnO NPs 的薄膜中 OB 的存活率降低。这一结果表明,尽管 ZnO NPs 可以提高纯 CS 薄膜的力学性能,但由于这些颗粒的细胞毒性作用,仅能将低百分比的 ZnO NPs 应用于生物医学和生物工程应用。